Episurf Medical entered into an agreement of SEK 1.5 million (~USD $0.2 million) for out-licensing of the µiFidelity® software platform.
µiFidelity is the communication and distribution arm of Episurf Medical’s orthopedic product line to treat articular cartilage damage and underlying bone lesions, where medical imaging constitutes a central part.
With this transaction, Episurf is licensing its platform to a U.S.-based orthopedic company, which intends to establish its own communication and distribution platform based on µiFidelity.
Episurf Medical entered into an agreement of SEK 1.5 million (~USD $0.2 million) for out-licensing of the µiFidelity® software platform.
µiFidelity is the communication and distribution arm of Episurf Medical’s orthopedic product line to treat articular cartilage damage and underlying bone lesions, where medical imaging constitutes a central...
Episurf Medical entered into an agreement of SEK 1.5 million (~USD $0.2 million) for out-licensing of the µiFidelity® software platform.
µiFidelity is the communication and distribution arm of Episurf Medical’s orthopedic product line to treat articular cartilage damage and underlying bone lesions, where medical imaging constitutes a central part.
With this transaction, Episurf is licensing its platform to a U.S.-based orthopedic company, which intends to establish its own communication and distribution platform based on µiFidelity.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
